Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease with a poor prognosis. Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Recently two drugs, pirfenidone and nintedanib, were approved for clinical use as they are able to slow down the disease progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehtonen, Siri T., Veijola, Anniina, Karvonen, Henna, Lappi-Blanco, Elisa, Sormunen, Raija, Korpela, Saara, Zagai, Ulrika, Sköld, Magnus C., Kaarteenaho, Riitta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743320/
https://www.ncbi.nlm.nih.gov/pubmed/26846335
http://dx.doi.org/10.1186/s12931-016-0328-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743320/
https://www.ncbi.nlm.nih.gov/pubmed/26846335
http://dx.doi.org/10.1186/s12931-016-0328-5

Ejemplares similares